Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes – Research and Markets – Yahoo Finance
|
Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes – Research and Markets
Yahoo Finance Nevertheless, metastatic melanoma remains incurable. Furthermore, in many studies in advanced melanoma and other cancers, only a minority of patients have benefited from immunotherapy treatments. Researchers and companies are therefore looking for … |
